Chenchen He

978 total citations
37 papers, 777 citations indexed

About

Chenchen He is a scholar working on Molecular Biology, Cancer Research and Building and Construction. According to data from OpenAlex, Chenchen He has authored 37 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Building and Construction. Recurrent topics in Chenchen He's work include Sustainable Building Design and Assessment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Chenchen He is often cited by papers focused on Sustainable Building Design and Assessment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Chenchen He collaborates with scholars based in China, United States and Netherlands. Chenchen He's co-authors include Suxia Han, Qing Zhu, Yechen Qin, Mingming Dong, Lijuan Wang, Jinlu Ma, Xinxin Shao, Changle Xiang, Xijing Guo and Haiping Du and has published in prestigious journals such as SHILAP Revista de lepidopterología, Renewable and Sustainable Energy Reviews and Journal of Cleaner Production.

In The Last Decade

Chenchen He

35 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenchen He China 16 289 173 114 107 106 37 777
Ho Park South Korea 15 383 1.3× 241 1.4× 135 1.2× 45 0.4× 27 0.3× 50 932
Wenguang Ye China 16 348 1.2× 201 1.2× 118 1.0× 18 0.2× 126 1.2× 36 912
Abul Kalam Azad Canada 19 289 1.0× 125 0.7× 277 2.4× 33 0.3× 189 1.8× 55 1.1k
Stefan Junk Germany 10 424 1.5× 94 0.5× 104 0.9× 23 0.2× 35 0.3× 49 841
Kevin S. Kung United States 15 344 1.2× 73 0.4× 366 3.2× 50 0.5× 48 0.5× 19 1.4k
Heng Zhou China 13 220 0.8× 108 0.6× 80 0.7× 20 0.2× 95 0.9× 27 961
Chenghu Zhang China 16 197 0.7× 49 0.3× 23 0.2× 169 1.6× 70 0.7× 68 908
Chia-Ying Lin Taiwan 16 202 0.7× 51 0.3× 122 1.1× 50 0.5× 45 0.4× 19 788
Zhaoyan Li China 15 365 1.3× 220 1.3× 119 1.0× 22 0.2× 8 0.1× 45 850
Jianqun Wang China 22 961 3.3× 707 4.1× 80 0.7× 23 0.2× 247 2.3× 87 1.9k

Countries citing papers authored by Chenchen He

Since Specialization
Citations

This map shows the geographic impact of Chenchen He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenchen He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenchen He more than expected).

Fields of papers citing papers by Chenchen He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenchen He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenchen He. The network helps show where Chenchen He may publish in the future.

Co-authorship network of co-authors of Chenchen He

This figure shows the co-authorship network connecting the top 25 collaborators of Chenchen He. A scholar is included among the top collaborators of Chenchen He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenchen He. Chenchen He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wang, Chenchen He, Changlin Li, et al.. (2024). Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death. Frontiers in Pharmacology. 15. 1397116–1397116. 4 indexed citations
3.
Ma, Yanfang, Yi Li, Wei Yuan, et al.. (2023). Cardiorespiratory dose comparison among six radiotherapy regimens for patients with left-sided breast cancer. Scientific Reports. 13(1). 13339–13339. 3 indexed citations
4.
He, Chenchen, et al.. (2023). Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers. Frontiers in Oncology. 13. 1087082–1087082. 1 indexed citations
5.
Zhang, Ying, Wei Wei, Changying Li, et al.. (2022). Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein. Cell Death and Disease. 13(12). 1034–1034. 3 indexed citations
6.
He, Chenchen, Yuanyuan Hou, Liping Ding, & Peng Li. (2021). Visualized literature review on sustainable building renovation. Journal of Building Engineering. 44. 102622–102622. 36 indexed citations
7.
8.
He, Chenchen, Shengjia Shi, Mincong Wang, et al.. (2021). Linc00963 Promote Cell Proliferation and Tumor Growth in Castration-Resistant Prostate Cancer by Modulating miR-655/TRIM24 Axis. Frontiers in Oncology. 11. 636965–636965. 20 indexed citations
9.
Wang, Jing, Yue Zhu, Chenchen He, et al.. (2021). SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway. Neoplasia. 23(10). 1037–1047. 16 indexed citations
10.
Liu, Tianya, Jin Yan, Chenchen He, et al.. (2021). A Tumor‐Targeting Metal‐Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade. Small. 18(3). e2104849–e2104849. 24 indexed citations
11.
Zhang, Yuanyuan, Ying Xia, Qian Zhao, et al.. (2020). Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ. Disease Markers. 2020. 1–10. 7 indexed citations
12.
He, Chenchen, Shiwei Yu, Qi Han, & Bauke de Vries. (2019). How to attract customers to buy green housing? Their heterogeneous willingness to pay for different attributes. Journal of Cleaner Production. 230. 709–719. 42 indexed citations
13.
Li, Changlin, Chenchen He, Ying Xu, et al.. (2019). Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. The Prostate. 79(6). 628–639. 32 indexed citations
14.
Sui, Xin, Jianye Cai, Hongyu Li, et al.. (2018). p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer. Cell Death and Disease. 9(5). 523–523. 25 indexed citations
15.
Huang, Hua, et al.. (2018). Analysis of Vertical Stiffness of Air Spring Based on Finite Element Method. SHILAP Revista de lepidopterología. 153. 6006–6006. 4 indexed citations
16.
Pan, Shupei, Yuchen Sun, Tian Yang, et al.. (2018). Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 102. 567–574. 19 indexed citations
17.
Ying, Xia, Yue Zhao, Jun-Lan Wang, et al.. (2014). Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Oncology Reports. 32(4). 1550–1556. 17 indexed citations
18.
Ma, Jinlu, Yaodong Li, Chenchen He, et al.. (2014). The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance. Journal of Immunology Research. 2014. 1–7. 19 indexed citations
19.
Han, Suxia, Xijing Guo, Chenchen He, et al.. (2014). Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma. Journal of Immunology Research. 2014. 1–7. 35 indexed citations
20.
Cao, Changqing, Kai Zhang, Chenchen He, Yanan Zhao, & Qingjie Guo. (2010). Investigation into a gas–solid–solid three-phase fluidized-bed carbonator to capture CO2 from combustion flue gas. Chemical Engineering Science. 66(3). 375–383. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ho Park Breakdown of academic impact, for papers by Wenguang Ye Breakdown of academic impact, for papers by Abul Kalam Azad Breakdown of academic impact, for papers by Stefan Junk Breakdown of academic impact, for papers by Kevin S. Kung Breakdown of academic impact, for papers by Heng Zhou Breakdown of academic impact, for papers by Chenghu Zhang Breakdown of academic impact, for papers by Chia-Ying Lin Breakdown of academic impact, for papers by Zhaoyan Li Breakdown of academic impact, for papers by Jianqun Wang
Rankless by CCL
2026